Evaluation of somatic and germline mutations in Chinese patients with gallbladder carcinoma reveals clinically actionable targets.

e16143Background: Gallbladder cancer (GBC) is an aggressive gastrointestinal cancer and the median survival of GBC patients is less than one year. Given the rarity of this disease, there is no enou...